Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6677962 | 0.89 | LMNA (0.32) | — | |
| SCHEMBL1535731 | 0.83 | LMNA (0.42) | ALDH1A1 | |
| SCHEMBL3128207 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL18059974 | 0.80 | LMNA (0.40) | ALDH1A1 | |
| SCHEMBL1804524 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL4696502 | 0.78 | ALDH1A1 (0.35) | ALDH1A1 | |
| Ethane SCHEMBL10715791 | 0.78 | — | — | |
| SCHEMBL11503836 | 0.77 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL2066532 | 0.77 | — | — | |
| SCHEMBL5698885 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12378193-B2 | Anti-arrhythmicity agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-08-05 | — | — | US | disclosed |
| US-20220127226-A1 | ANTI-ARRHYTHMICITY AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-28 | — | — | US | disclosed |
| EP-3233895-B1 | ANTI-ARRHYTHMICITY AGENTS | UNIV CALIFORNIA (US) | 2021-08-18 | — | — | EP | disclosed |
| US-20170362173-A1 | ANTI-ARRHYTHMICITY AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-12-21 | — | — | US | disclosed |
| EP-3233895-A1 | ANTI-ARRHYTHMICITY AGENTS | The Regents of The University of California (US) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016100379-A1 | ANTI-ARRHYTHMICITY AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362173-A1 | ANTI-ARRHYTHMICITY AGENTS | KCNH1, TNNI3, TNNC1 | ALDH1A1 806/4885 |
| US-12378193-B2 | Anti-arrhythmicity agents | KCNH1, TNNI3, TNNC1 | ALDH1A1 806/4885 |
| US-20220127226-A1 | ANTI-ARRHYTHMICITY AGENTS | KCNH1, TNNI3, TNNC1 | ALDH1A1 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.